Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Tian J, Guo L, Sui S, Driskill C, Phensy A, Wang Q, Gauba E, Zigman JM, Swerdlow RH, Kroener S, Du H.

Sci Transl Med. 2019 Aug 14;11(505). pii: eaav6278. doi: 10.1126/scitranslmed.aav6278.

PMID:
31413143
2.

Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia.

Phensy A, Driskill C, Lindquist K, Guo L, Jeevakumar V, Fowler B, Du H, Kroener S.

eNeuro. 2017 Aug 17;4(4). pii: ENEURO.0081-17.2017. doi: 10.1523/ENEURO.0081-17.2017. eCollection 2017 Jul-Aug.

3.

Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment.

Phensy A, Duzdabanian HE, Brewer S, Panjabi A, Driskill C, Berz A, Peng G, Kroener S.

Front Behav Neurosci. 2017 Jun 6;11:106. doi: 10.3389/fnbeh.2017.00106. eCollection 2017.

4.

Increasing the GluN2A/GluN2B Ratio in Neurons of the Mouse Basal and Lateral Amygdala Inhibits the Modification of an Existing Fear Memory Trace.

Holehonnur R, Phensy AJ, Kim LJ, Milivojevic M, Vuong D, Daison DK, Alex S, Tiner M, Jones LE, Kroener S, Ploski JE.

J Neurosci. 2016 Sep 7;36(36):9490-504. doi: 10.1523/JNEUROSCI.1743-16.2016.

5.

Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.

Beck SJ, Guo L, Phensy A, Tian J, Wang L, Tandon N, Gauba E, Lu L, Pascual JM, Kroener S, Du H.

Nat Commun. 2016 May 6;7:11483. doi: 10.1038/ncomms11483.

Supplemental Content

Loading ...
Support Center